These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
679 related articles for article (PubMed ID: 8690806)
1. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806 [TBL] [Abstract][Full Text] [Related]
2. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767 [TBL] [Abstract][Full Text] [Related]
3. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis. Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA Ann N Y Acad Sci; 1996 Feb; 778():251-7. PubMed ID: 8610978 [TBL] [Abstract][Full Text] [Related]
4. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179 [TBL] [Abstract][Full Text] [Related]
5. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
7. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Takashima H; Smith DR; Fukaura H; Khoury SJ; Hafler DA; Weiner HL Clin Immunol Immunopathol; 1998 Jul; 88(1):28-34. PubMed ID: 9683547 [TBL] [Abstract][Full Text] [Related]
8. Autoreactive T and B cells in nervous system diseases. Sun JB Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894 [TBL] [Abstract][Full Text] [Related]
9. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients. Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503 [TBL] [Abstract][Full Text] [Related]
11. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644 [TBL] [Abstract][Full Text] [Related]
12. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366 [TBL] [Abstract][Full Text] [Related]
13. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. al-Sabbagh A; Miller A; Santos LM; Weiner HL Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160 [TBL] [Abstract][Full Text] [Related]
14. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813 [TBL] [Abstract][Full Text] [Related]
15. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. Chen Y; Inobe J; Weiner HL J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ; Kennedy KJ; Smith WS; Miller SD J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901 [TBL] [Abstract][Full Text] [Related]
17. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Santos LM; al-Sabbagh A; Londono A; Weiner HL Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838 [TBL] [Abstract][Full Text] [Related]
18. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026 [TBL] [Abstract][Full Text] [Related]
19. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta. Link J; Söderström M; Kostulas V; Olsson T; Höjeberg B; Ljungdahl A; Link H J Neuroimmunol; 1994 Jan; 49(1-2):9-18. PubMed ID: 7507500 [TBL] [Abstract][Full Text] [Related]
20. Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Link J; Söderström M; Ljungdahl A; Höjeberg B; Olsson T; Xu Z; Fredrikson S; Wang ZY; Link H Neurology; 1994 Apr; 44(4):728-34. PubMed ID: 7513071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]